Hemlata Kaurav

640 total citations
43 papers, 363 citations indexed

About

Hemlata Kaurav is a scholar working on Complementary and alternative medicine, Plant Science and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Hemlata Kaurav has authored 43 papers receiving a total of 363 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Complementary and alternative medicine, 14 papers in Plant Science and 12 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Hemlata Kaurav's work include Natural Antidiabetic Agents Studies (12 papers), Phytochemicals and Medicinal Plants (10 papers) and Ethnobotanical and Medicinal Plants Studies (7 papers). Hemlata Kaurav is often cited by papers focused on Natural Antidiabetic Agents Studies (12 papers), Phytochemicals and Medicinal Plants (10 papers) and Ethnobotanical and Medicinal Plants Studies (7 papers). Hemlata Kaurav collaborates with scholars based in India, Belarus and United States. Hemlata Kaurav's co-authors include Deepak N. Kapoor, Amit Bansal, Sandeep Sheth, S L Harikumar, Amanpreet Kaur, Srinivasan Madhusudan, Simran Kaur, Om Prakash Katare, Kamal Dua and Ashish Sharma and has published in prestigious journals such as Biotechnology and Bioengineering, Pharmaceutics and Frontiers in Chemistry.

In The Last Decade

Hemlata Kaurav

41 papers receiving 326 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hemlata Kaurav India 11 89 76 73 66 49 43 363
Mukul Tailang India 10 74 0.8× 42 0.6× 62 0.8× 73 1.1× 46 0.9× 30 370
Ganesh H. Wadkar India 12 106 1.2× 54 0.7× 62 0.8× 123 1.9× 48 1.0× 21 395
Alakh N. Sahu India 13 89 1.0× 82 1.1× 150 2.1× 144 2.2× 68 1.4× 46 579
Ibrahim Abdel Aziz Ibrahim Saudi Arabia 14 66 0.7× 62 0.8× 101 1.4× 119 1.8× 67 1.4× 45 470
Wan Mohd Azizi Wan Sulaiman Malaysia 10 67 0.8× 63 0.8× 71 1.0× 27 0.4× 23 0.5× 19 390
Komgrit Eawsakul Thailand 12 52 0.6× 27 0.4× 63 0.9× 54 0.8× 41 0.8× 30 316
Krishnaraju Venkatesan Saudi Arabia 13 80 0.9× 47 0.6× 117 1.6× 44 0.7× 27 0.6× 65 499
Ashutosh Pareek India 12 215 2.4× 57 0.8× 103 1.4× 35 0.5× 83 1.7× 45 602
Vadivel Arulmozhi India 7 101 1.1× 66 0.9× 91 1.2× 172 2.6× 77 1.6× 8 501
Sepideh Bohlouli Iran 8 76 0.9× 42 0.6× 125 1.7× 38 0.6× 21 0.4× 21 461

Countries citing papers authored by Hemlata Kaurav

Since Specialization
Citations

This map shows the geographic impact of Hemlata Kaurav's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hemlata Kaurav with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hemlata Kaurav more than expected).

Fields of papers citing papers by Hemlata Kaurav

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hemlata Kaurav. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hemlata Kaurav. The network helps show where Hemlata Kaurav may publish in the future.

Co-authorship network of co-authors of Hemlata Kaurav

This figure shows the co-authorship network connecting the top 25 collaborators of Hemlata Kaurav. A scholar is included among the top collaborators of Hemlata Kaurav based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hemlata Kaurav. Hemlata Kaurav is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Upadhyay, Navneet Kumar, et al.. (2025). Formulation and evaluation of famotidine-loaded nanosponges for the treatment of peptic ulcer: In vitro and in vivo evaluation. Journal of Applied Pharmaceutical Science.
2.
Bansal, Amit, et al.. (2025). Intranasal Mucoadhesive In Situ Gel of Glibenclamide-Loaded Bilosomes for Enhanced Therapeutic Drug Delivery to the Brain. Pharmaceutics. 17(2). 193–193. 5 indexed citations
3.
Kaurav, Hemlata, et al.. (2024). Emerging Trends in Bilosomes as Therapeutic Drug Delivery Systems. Pharmaceutics. 16(6). 697–697. 20 indexed citations
4.
Kaurav, Hemlata, et al.. (2023). Progress in drug delivery and diagnostic applications of carbon dots: a systematic review. Frontiers in Chemistry. 11. 1227843–1227843. 59 indexed citations
5.
Sharma, Avinash, et al.. (2023). An insight into biosensing platforms used for the diagnosis of various lung diseases: A review. Biotechnology and Bioengineering. 121(1). 71–81. 1 indexed citations
6.
Kaurav, Hemlata, et al.. (2021). BRAHMI (BACOPA MONNIERI)– A POTENTIAL AYURVEDIC COGNITIVE ENHANCER AND NEUROPROTECTIVE HERB. International Journal of Ayurveda and Pharma Research. 41–49. 7 indexed citations
7.
Kaurav, Hemlata, et al.. (2021). Daruharidra (Berberis aristata): Review based upon its Ayurvedic Properties. 8(2). 98–106. 18 indexed citations
8.
Kaurav, Hemlata, et al.. (2021). GOKHRU (TRIBULUS TERRESTRIS AND PEDALIUM MUREX): MEDICINAL IMPORTANCE OF CHOTA GOKHRU AND BADA GOKHRU IN AYURVEDA AND MODERN SCIENCE. Asian Journal of Pharmaceutical and Clinical Research. 6–13. 3 indexed citations
9.
Kaurav, Hemlata, et al.. (2021). HEMIDESMUS INDICUS (ANANTMOOL): A POTENTIAL TRADITIONAL PLANT WITH ANTIVENOM ACTIVITY. International Journal of Research in Ayurveda and Pharmacy. 12(3). 106–112. 2 indexed citations
10.
Kaurav, Hemlata, et al.. (2021). Nigella sativa (Kalonji): A Black Seed of Miracle. International Journal of Research and Review. 8(4). 342–357. 18 indexed citations
11.
Kaurav, Hemlata, et al.. (2021). Colchicum autumnale (suranjan): A cytotoxic plant with anti-arthritis properties. 6(3). 80–86. 1 indexed citations
12.
Kaurav, Hemlata, et al.. (2021). Terminalia arjuna: A Potential Ayurvedic Cardio Tonic. 8(2). 227–236. 12 indexed citations
13.
Kaurav, Hemlata, et al.. (2021). WHEATGRASS (TRITICUM AESTIVUM LINN.): A POTENTIAL SUBSTITUTE OF HUMAN BLOOD IN TRADITIONAL SYSTEM OF MEDICINE. Asian Journal of Pharmaceutical and Clinical Research. 43–47. 8 indexed citations
14.
Kaurav, Hemlata, et al.. (2021). ADHATODA VASICA (VASAPATRA): A REVIEW BASED UPON ITS MEDICINAL PROPERTIES. International Journal of Research in Ayurveda and Pharmacy. 12(3). 79–87. 2 indexed citations
15.
Kaurav, Hemlata, et al.. (2021). BOERHAVIA DIFFUSA (PUNARNAVA): A REVIEW BASED ON ITS AYURVEDIC AND MODERN THERAPEUTIC USES. International Journal of Research in Ayurveda and Pharmacy. 12(2). 124–131. 1 indexed citations
16.
Kaurav, Hemlata, et al.. (2021). Citraka (Plumbago zeylanica): A Potential Rejuvenator. 8(2). 202–212. 5 indexed citations
17.
Kaurav, Hemlata, et al.. (2021). NARDOSTACHYS JATAMANSI: IMPORTANCE OF HIGHLY SIGNIFICANT AND ENDANGERED PLANT IN AYURVEDA. International Journal of Research in Ayurveda and Pharmacy. 12(3). 124–130. 6 indexed citations
18.
Kaurav, Hemlata, et al.. (2021). Rubia cordifolia (Manjishtha): A review based upon its Ayurvedic and Medicinal uses. 17–28. 6 indexed citations
19.
Kaurav, Hemlata, S L Harikumar, & Amanpreet Kaur. (2013). Design and Characterization of sustained release Microspheres ofAcarbose. International Journal of Drug Development and Research. 5(1). 3 indexed citations
20.
Kaurav, Hemlata, S L Harikumar, & Amanpreet Kaur. (2012). Mucoadhesive Microspheres as carriers in Drug Delivery: a Review. International Journal of Drug Development and Research. 4(2). 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026